HLA-B and AIDS: Patients with HIV have provided the first evidence that KIR3DL1 and HLA-B compound allotypes can variably influence disease outcomes, whereby highly-inhibitory combinations of Bw4-80I and KIR3DL1-high alleles best protect against progression to AIDS [8].